Effect of Telehealth and Mailed Pills on the Distance-to-Clinic Abortion Response

What the evidence says

Telehealth and mailed pills change how far patients travel, and the studies here measure that most directly in pre-post designs. In a pre-post study of clinic-to-clinic telemedicine for medication abortion, telemedicine was associated with a small decrease in travel distance to the clinic. The same study found an increase in the probability of receiving a medication abortion and of undergoing a first trimester abortion. A retrospective records review of Montana found the mean one-way distance fell from 134 to 115 miles. Nevada's fell from 47 to 34 miles. A third analysis found users travelled 3.16 miles less on average after telemedicine was introduced. None of these three distance estimates has a control group.

The distance effect is larger for patients far from clinics. Among women living more than 50 miles from the nearest clinic offering surgical abortion, those in a sample of 17,956 were more likely to obtain an abortion after telemedicine was introduced. The paper reports this as "more likely" without an odds ratio. Simulation research, cited in a discussion section rather than tested directly, projects the same direction: lifting state telehealth restrictions would improve access, particularly for people living 50 miles or more from a facility. Another simulation cited there finds that making telehealth abortion widely available would be associated with increased access and reduced unmet need. A modeling estimate of the federal in-person dispensing requirement (the REMS) puts the avoidable load at nearly 2 million clinical abortion contacts during the pandemic. These modeled figures are not validated against observed behavior.

The mechanism the sources name is removal of the trip. Telehealth models with mailed medication eliminate the need to travel, and they reduce costs such as accommodation, lost wages and childcare. Patients in qualitative work preferred telemedicine because mailed medication removed the need for transportation and childcare. Long distance from home was among the most common reasons patients gave for preferring telemedicine. These claims rest on user perceptions and cited studies. They do not give a measured distance reduction.

Distance also relates to outcomes without telemedicine. In a prospective cohort, living 50 miles or more from the facility was associated with seeking an abortion or planning to continue the pregnancy four weeks later. The source gives no effect size.

Evidence on pandemic-era remote services is mixed. A scoping review found nine studies reporting increased access and use of remote or partially remote abortion services in countries with relatively liberal abortion laws. Two other studies in the same review observed declines in at-home medical abortion use. A separate systematic review of telehealth for reproductive health found abortion evidence insufficient, so it supports no direction on abortion outcomes.

Where the evidence splits

Average travel distance versus median distance. Three studies find mean distance fell after telemedicine, by 3.16, 19 and 13 miles. A single-clinic retrospective cohort found the median distance was 7 miles for both telemedicine and in-clinic users. The sources do not say whether the difference comes from mean versus median, from a before-after comparison versus a cross-sectional one, or from the clinics' catchment areas. The split is unexplained by the sources on this page.

Direction of remote abortion use during COVID-19. Nine studies found increased use of remote or partially remote services, while Endler et al and DeKort et al observed declines in at-home medical abortion use. The review does not say what separates these studies, so the split is unexplained here.

Country-level requests. Requests through the online service Women on Web increased in Portugal, Italy, Hungary, Malta and Northern Ireland and decreased in the UK. The source gives a speculated explanation: a UK legal change that increased no-test abortions through the formal health sector. The source marks this as speculation, not a tested finding.

Modeled versus observed travel. Telemedicine patients would have travelled 65 miles, against 21 for in-person patients, had they used in-clinic services. The claim does not say whether the 65 miles is measured or modeled. It sits beside the 7-mile equal medians without any stated reconciliation.

Thresholds and dose-response

Three sources use 50 miles as a cutoff. After telemedicine introduction, women living more than 50 miles from the nearest clinic offering surgical abortion were more likely to obtain an abortion. Simulation work projects the largest access gains for people 50 miles or more from a facility. Living 50 miles or more away was associated with seeking an abortion or planning to continue pregnancy four weeks later. No source here tests other distance cutoffs or gives a dose-response curve, so the sources do not show whether 50 miles is where the effect begins.

Open empirical questions

• What is the distance reduction for patients living more than 50 miles away, measured against a control group and not only before and after?
• Do the mean distance reductions in Montana and Nevada hold in states with different clinic geography, and why does one clinic's median distance show no difference?
• Did the pandemic-era changes in remote abortion use persist afterward, and what explains the declines in at-home medical abortion use in some studies?
• Do modeled access gains, such as the 2 million avoided clinical contacts, match what patients did once mailed pills were available?